These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37052778)

  • 1. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic telogen effluvium.
    Whiting DA
    Dermatol Clin; 1996 Oct; 14(4):723-31. PubMed ID: 9238330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
    Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S
    J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
    Whiting DA
    J Am Acad Dermatol; 1996 Dec; 35(6):899-906. PubMed ID: 8959948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of hair loss after COVID-19: A systematic scoping review.
    Czech T; Sugihara S; Nishimura Y
    J Cosmet Dermatol; 2022 Sep; 21(9):3655-3662. PubMed ID: 35801366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent modalities in treatment of telogen effluvium: Comparative study.
    Khattab FM; Rady A; Khashaba SA
    Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute telogen effluvium triad after resolution.
    Contin LA; Rocha VB
    An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
    Daly T; Daly K
    J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telogen Effluvium: A Review of the Literature.
    Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
    Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic telogen effluvium: a study of 5 patients over 7 years.
    Sinclair R
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):12-6. PubMed ID: 15692504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.
    Savci U; Senel E; Oztekin A; Sungur M; Erel O; Neselioglu S
    An Bras Dermatol; 2020; 95(4):447-451. PubMed ID: 32482549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anagen effluvium.
    Kanwar AJ; Narang T
    Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.